Docetaxel enhances tumor radioresponse in vivo

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2431-2438

  Mason, Kathryn A ^a   Hunter, Nancy R ^a   Milas, Mira ^b   Abbruzzese, James L ^b   Milas, Luka ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; PINAVERIUM BROMIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CANCER RADIOTHERAPY; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; JEJUNUM; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL SURVIVAL; COMBINED MODALITY THERAPY; FEMALE; INTESTINAL MUCOSA; JEJUNUM; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; PACLITAXEL; RADIOTHERAPY DOSAGE; TAXOIDS; TRANSPLANTATION, ISOGENEIC; WHOLE-BODY IRRADIATION;

EID: 0031431542     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Milross, C. G., Mason, K. A., Hunter, N. R., Chung, W. K., Peters, L. J., and Milas, L. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J. Natl. Cancer Inst., 88: 1308-1314, 1996.
2. Rowinsky, E. K., and Donehower, R. C. Paclitaxel (Taxol). N. Engl. J. Med., 332: 1004-1014, 1995.
3. Bissery, M. C., Vrignaud, P., and Lavelle, F. Preclinical profile of docetaxel (Taxotere): efficacy as a single agent and in combination. Semin. Oncol., 22 (Suppl. 13): 3-16, 1995.
4. Fossella, F. V., Lee, J. S., Murphy, W. K., Lippman, S. M., Calayag, M., Pang, A., Chosen, M., Shin, D. M., Glisson, B., Benner, S., Huber, M., Perez-Soler, R., Hong, W. K., and Raber, M. Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer. J. Clin. Oncol., 12: 1238-1244, 1994.
5. Chevallier, B., Fumoleau, P., Kerbrat, P., Dieras, V., Roche, H., Krakowski, L, Azli, N., Bayssas, M., Leutz, M. A., and Van Glabbeke, M. Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a Phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer. J. Clin. Oncol., 13: 314-322, 1995.
6. Piccart, M. J., Gore, M., Huinink, W. T. B., Van Oosterom, A., Verweij, J., Wanders, J., Franklin, H., Bayssas, M., and Kaye, S. Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer. J. Natl. Cancer Inst., 87: 676-681, 1995.
7. Tishler, R. B., Geard, C. R., Hall, E. J., and Schiff, P. B. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res., 52: 3495-3497, 1992.
8. Bhalla, K., Ilerado, A. M., Tourkina, E., Tang, C., Mahoney, M. E., and Huang, Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia (Baltimore), 7: 563-568, 1993.
9. Liebmann, J., Cook, J. A., Fisher, J., Teague, D., and Mitchell, J. B. In vitro studies of Taxol as a potential radiation sensitizer. J. Natl. Cancer Inst., 86: 441-446, 1994.
10. Hanauske, A. R., Degen, D., Hilsenbeck, S. G., Bissery, M. C., and Von Hoff, D. D. Effects of taxotere and Taxol on in vitro colony formation of freshly explanted human tumor cells. Anticancer Drugs, 3: 121-124, 1992.
11. Kelland, L. R., and Abel, G. Comparative in vitro cytotoxicity of Taxol and taxotere against cisplatin-sensitive and -resistant human ovarian cancer cell lines. Cancer Chemother. Pharmacol., 30: 444-450, 1992.
12. Schiff, P. B., Fant, S., and Horwitz, S. B. Promotion of microtubule assembly in vitro by Taxol. Nature (Lond.), 277: 665-667, 1979.
13. Schiff, P. B., and Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA, 77: 1561-1565, 1980.
14. Gueritte-Voegelein, F., Guenard, D., Lavelle, F., Le Goff, M. T., Mangatal, L., and Potier, P. Relationships between the structure of Taxol analogues and their antimitotic activity. J. Med. Chem., 34: 992-998, 1991.
15. Gangemi, R. M. R., Tiso, M., Marchetti, C., Seven, A. B., and Fabbi, M. Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother. Pharmacol., 36: 385-392, 1995.
16. Milas, L., Hunter, N. R., Kurdoglu, B., Mason, K. A., Meyn, R. E., Stephens, L. C., and Peters, L. J. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with Taxol. Cancer Chemother. Pharmacol., 35: 297-303, 1995.
17. Terry, N. H. A., Milross, C. G., Patel, N., Mason, K. A., White, R. A., and Milas, L. The effect of paclitaxel on the cell cycle kinetics of a mammary tumor in vivo. Breast J., 3: 99-105, 1997.
18. Ringel, I., and Horwitz, S. B. Studies with RP 56976 (Taxotere): a semisynthetic analogue of Taxol. J. Natl. Cancer Inst., 83: 288-291, 1992.
19. Lavelle, F., Bissery, M. C., Combeau, C., Riou, J. F., Vrignaud, P., and Andre, S. Preclinical evaluation of docetaxel (Taxotere). Semin. Oncol., 22 (Suppl. 4): 3-16, 1995.
20. Terasima, T., and Tolmach, L. J. Variations in several responses of HeLa cells to X-irradiation during the division cycle. Biophys. J., 3: 11-33, 1963.
21. Sinclair, W. K., and Morton, R. A. X-ray sensitivity during the cell generation cycle of cultured Chinese hamster ovary cells. Radiat. Res., 29: 450-474, 1966.
22. Withers, H. R., Mason, K. A., Reid, B. O., Dubravsky, N., Barkley, H. T., and Brown, B. W. Response of mouse intestine to neutrons and gamma rays in relation to dose fractionation and division cycle. Cancer (Phila.), 34: 39-47, 1974.
23. Choy, H., Rodriguez, F. F., Koester, S., Hilsenbeck, S., and Von Hoff, D. D. Investigation of Taxol as a potential radiation sensitizer. Cancer (Phila.), 71: 3774-3778, 1993.
24. Hennequin, C., Giocanti, N., and Favaudon, V. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells. Cancer Res., 56: 1842-1850, 1996.
25. Steren, A., Sevin, B. U., Perras, J., Angioli, R., Nguyen, H., Guerra, L., Koechli, O., and Averette, H. E. Taxol sensitizes human ovarian cancer cells to radiation. Gynecol. Oncol., 48: 252-258, 1993.
26. Milas, L., Hunter, N. R., Mason, K. A., Kurdoglu, B., and Peters, L. J. Enhancement of tumor radioresponse of a murine mammary carcinoma by Taxol. Cancer Res., 54: 3506-3510, 1994.
27. Mason, K. A., Milas, L., and Peters, L. J. Effect of paclitaxel (Taxol) alone and in combination with radiation on the gastrointestinal mucosa. Int. J. Radiat. Oncol. Biol. Phys., 32: 1381-1389, 1995.
28. Milas, L., Hunter, N. R., Mason, K. A., Milross, C. G., Saito, Y., and Peters, L. J. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res., 55: 3564-3568, 1995.
29. Milas, L., Saito, Y., Hunter, N. R., Milross, C. G., and Mason, K. A. Therapeutic potential of paclitaxel radiation treatment of a murine ovarian carcinoma. Radiother. Oncol., 40: 163-170, 1996.
30. Milross, C. G., Mason, K. A., Hunter, N. R., Terry, N. H. A., Patel, N., Harada, S., Jibu, T., Seong, J., and Milas, L. Enhanced radioresponse of paclitaxel-sensitive and -resistant tumors in vivo. Eur. J. Cancer, 33: 1294-1308, 1997.
31. Joschko, M. A., Webster, L. K., Groves, J., Ball, D. L., and Bishop. J. F. Taxol enhances radiation effect in a hypopharyngeal xenograft. Forty-second Annual Meeting of the Radiation Research Society, Book of Abstracts, p. 206. Oak Brook, IL: Radiation Research Society, 1994.
32. Milas, L., Hunter, N., Mason, K., and Withers, H. R. Immunologic resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res., 34: 61-71, 1974.
33. Stephens, L. C., Ang, K. K., Schulteiss, T. E., Milas, L., and Meyn, R. E. Apoptosis in irradiated murine tumors. Radiat. Res., 127: 308-316, 1991.
34. Weil, M. M., Stephens, L. C., Amos, C. I., Ruifrok, A. C., and Mason, K. A. Strain difference in jejunal crypt susceptibility to radiation-induced apoptosis. Int. J. Radiat. Biol., 70: 579-585, 1996.
35. Withers, H. R., and Elkind, M. M. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int. J. Radiat. Biol., 17: 261-267, 1970.
36. Griffon-Etienne, G., Boucher, Y., Taghian, A., Jain, R. K., and Suit, H. D. Effects of paclitaxel and docetaxel on oxygen partial pressure and interstitial fluid pressure in experimental tumors. Forty-fifth Annual Meeting of the Radiation Research Society, Book of Abstracts, p. 154. Oak Brook, IL: Radiation Research Society, 1997.
37. Hennequin, N., Giocanti, N., and Favaudon, V. S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells. Br. J. Cancer, 71: 1194-1198, 1995.
38. Milas, L., and Scott, M. T. Antitumor activity of Corynebacterium parvum. Adv. Cancer Res., 26: 257-306, 1977.
39. Ding, A. H., Porteu, F., Sanchez, E., and Nathan, C. F. Shared actions of endotoxin and Taxol on TNF receptors and TNF release. Science (Washington DC), 248: 370-372, 1990.
40. Bogden, C., and Ding, A. H. Taxol, a microtubule stabilizing antineoplastic agent, induces expression of tumor necrosis-a and interleukin-1 in macrophages. J. Leukocyte Biol., 52: 119-121, 1992.
41. Burkhart, C. A., Berman, J. W., Swindell, C. S., and Horwitz, S. B. Relationship between the structure of Taxol and other taxanes on induction of tumor necrosis-α gene expression and cytotoxicity. Cancer Res., 54: 5779-5782, 1994.
42. Milas, L., Hunter, N., and Withers, H. R. Combination of local irradiation with systemic application of anaerobic Corynebacteria in therapy of a murine fibrosarcoma. Cancer Res., 35: 1274-1277, 1975.
43. Milas, L., Furuta, Y., Hunter, N., Nishiguchi, I., and Runkel, S. Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence. Cancer Res., 50: 4473-4477, 1990.